Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 2, 2015, Pages 312-318

  Wobb, Jessica L ^a   Chen, Peter Y ^a   Shah, Chirag ^b   Moran, Meena S ^c   Shaitelman, Simona F ^d   Vicini, Frank A ^e   Mbah, Alfred K ^f   Lyden, Maureen ^f   Beitsch, Peter ^g  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e 21ST CENTURY ONCOLOGY   (United States)

^f BioStat International Inc   (United States)

^g Dallas Breast Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORECASTING; IRRADIATION; NOMOGRAMS; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS; SCALES (WEIGHING INSTRUMENTS);

ACCELERATED PARTIAL BREAST IRRADIATION; CLINICOPATHOLOGIC VARIABLES; CONFORMAL RADIATION THERAPY; EARLY-STAGE BREAST CANCER; LOCOREGIONAL RECURRENCE; METHODS AND MATERIALS; PROPORTIONAL HAZARDS; UNIVARIATE ANALYSIS;

PATIENT TREATMENT;

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY BALLOON CATHETER; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLIMACTERIUM; CLINICAL PROTOCOL; DISEASE COURSE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; PATIENT SELECTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL BIAS; UNIVARIATE ANALYSIS; VERY ELDERLY; ALGORITHM; BREAST NEOPLASMS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT; PROCEDURES; PROGNOSIS; RADIATION DOSE FRACTIONATION; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BRACHYTHERAPY; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; ORGAN SPARING TREATMENTS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84922470680     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.09.029     Document Type: Article

References (35)

1. Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial. Radiother Oncol 2013;108:197-202.
2. Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation results of a matched-pair analysis. Radiother Oncol 2011;100:210-214.
3. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiotherapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010;77:1120-1127.
4. Polgar C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial-breast (APBI) after breast-conserving surgery: Recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010;94:264-273.
5. Keisch M, Arthur D, Patel R, et al. American Brachytherapy Society Breast Brachytherapy Task Group. Available at: http://www.american brachytherapy.org/guidelines/abs-breast-brachytherapy-taskgroup.pdf. Accessed March 30, 2014.
6. The American Society of Breast Surgeons. The American Society of Breast Surgeons consensus statement for accelerated partial breast irradiation. Available at: https://www.breastsurgeons.org/statements/PDF-Statements/APBI-statement-revised-100708.pdf. Accessed March 30, 2014.
7. Smith BD, Arther DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009;74:987-1001.
8. Coulombe G, Tyldesley S, Speers C, et al. Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 2007;67:1282-1290.
9. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 2001;19:1688-1697.
10. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-1015.
11. Houvenaeghel G, Goncalves A, Classe JM, et al. Characteristics and clinical outcome of T1 breast cancer: A multicenter retrospective cohort. Ann Oncol 2014;25:623-628.
12. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124:966-978.
13. Vicini F, Arthur D, Wazer D, et al. Limitations of the American Society of Therapeutic Radiology and Oncology census panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol 2011;79(4):977-984.
14. Christoudias MK, Collett AE, Stull TS, et al. Are the American Society for Radiation Oncology guidelines accurate predictors of recurrence in early stage breast cancer patients treated with balloonbased brachytherapy? Int J Surg Oncol 2013;2013:1-7.
15. Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010;28:3762-3769.
16. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400-418.
17. Bijker N, Meijnen P, Peterse JL, et al. Breast conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853da study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-3387.
18. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008;26:1247-1252.
19. Wilkinson JB, Beitsch PD, Shah C, et al. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial data. Int J Radiat Oncol Biol Phys 2012;85(5):1179-1185.
20. Shah C, Wilkinson JB, Lyden M, et al. Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. Int J Radiat Oncol Biol Phys 2012;82(5):e825-e830.
21. Goyal S, Khan AJ, Vicini FA, et al. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Registry Trial. Ann Surg Oncol 2009;16:2450-2458.
22. Shaitelman SF, Vicini FA, Beitsch P, et al. Five year outcomes of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation. Cancer 2010;116:4677-4685.
23. Vicini FA, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011;79:808-817.
24. Kattan MW, Yu C, Salomon L, et al. Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer. Urology 2011;77:396-401.
25. Sweldons C, Peeters S, van Limbergen E, et al. Local relapse after breastconserving therapy for ductal carcinoma in situ: A European single-center experience and external validation of the Memorial Sloan Kettering cancer center DCIS nomogram. Cancer J 2014;20:1-7.
26. Effron B. TJR: An Introduction to the Bootstrap. New York: Chapman and Hall; 2005.
27. Husain ZA, Mahmood U, Hanlon A, et al. Accelerated partial breast irradiation via brachytherapy: A patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy 2011;10:479-485.
28. ® breast brachytherapy registry trial. Ann Surg Oncol 2013;20(10):3279-3285.
29. Wobb J, Wilkinson JB, Shah C, et al. Impact of the number of cautionary and/or unsuitable risk factors on outcomes after accelerated partial breast irradiation. Int J Radiat Oncol Biol 2013;87(1):134-138.
30. Smith GL, Jiang J, Buchholz TA, et al. Benefit of adjuvant brachytherapy versus external beam radiation for early stage breast cancer: Impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys 2014;88:274-284.
31. Chen PY Accelerated partial breast irradiation: keeping guidelines in step with evolving data. Int J Radiat Oncol Biol Phys 2014;88(2):263-265.
32. Matsuda N, Hayashi N, Yagata OS, et al. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy. J Surg Oncol 2014;109:764-769.
33. Pleijhuis RG, Kwast AB, Jansen L, et al. A validated web-based nomogram for predicting positive surgical margins following breastconserving surgery as a preoperative tool for clinical decision-making. Breast 2013;22:773-779.
34. Hirabayashi S, Kosugi S, Isobe Y, et al. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer. Ann Oncol 2014;25:1179-1184.
35. Hamada T, Nakai Y, Yasunaga H, et al. Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy. Br J Cancer 2014;110:1943-1949.